Starling Oncology, Inc.
STLNNasdaqCIK 1799191HealthcareFiscal year ends Dec 31
Reports and events: 146 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-0220:41 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001079973-26-001208 |
| 2026-08-2117:25 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001079973-26-001169 |
| 2026-08-0616:36 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001799191-26-000017 |
| 2026-08-0616:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001079973-26-001006 |
| 2026-08-0309:00 ET | 8-K | 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001079973-26-000997 |
| 2026-07-0717:00 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001079973-26-000934 |
| 2026-06-1816:30 ET | 8-K | 5.07 Shareholder vote results | 0001553350-26-000093 |
| 2026-05-2216:30 ET | 8-K | 1.05 Material cybersecurity incident; 9.01 Financial statements and exhibits | 0001079973-26-000721 |
| 2026-05-1516:30 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001213900-26-057832 |
| 2026-05-0716:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001079973-26-000611 |
| 2026-05-0716:11 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001799191-26-000010 |
| 2026-04-3016:16 ET | DEF 14A | Proxy statementPeriod 2026-06-17 | 0001193125-26-197350 |
| 2026-03-1317:16 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001079973-26-000304 |
| 2026-03-1216:56 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001799191-26-000007 |
| 2026-03-1216:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001079973-26-000291 |
| 2026-02-2316:44 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001553350-26-000007 |
| 2026-01-1208:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001079973-26-000068 |
| 2026-01-0717:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001079973-26-000051 |
| 2025-12-0116:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001553350-25-000168 |
| 2025-11-2016:01 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001213900-25-113108 |
| 2025-11-1406:18 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001079973-25-001724 |
| 2025-11-1316:19 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001799191-25-000036 |
| 2025-11-1316:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001079973-25-001707 |
| 2025-11-0616:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001079973-25-001666 |
| 2025-09-0516:05 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001213900-25-085013 |
| 2025-08-1317:12 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001628280-25-040225 |
| 2025-08-1316:21 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001079973-25-001264 |
| 2025-08-1316:16 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001079973-25-001263 |
| 2025-05-1917:07 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001079973-25-000905 |
| 2025-05-1416:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001079973-25-000800 |
| 2025-05-1416:23 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001628280-25-025507 |
| 2025-05-0816:55 ET | 8-K | 5.07 Shareholder vote results | 0001079973-25-000774 |
| 2025-05-0716:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001079973-25-000764 |
| 2025-04-2318:20 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-25-038121 |
| 2025-04-1108:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001079973-25-000610 |
| 2025-03-2820:55 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001013762-25-004366 |
| 2025-03-2706:06 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001079973-25-000486 |
| 2025-03-2706:05 ET | DEF 14A | Proxy statementPeriod 2025-05-07 | 0001193125-25-064588 |
| 2025-03-2618:55 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001799191-25-000014 |
| 2025-03-2506:05 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001079973-25-000460 |
| 2025-03-2407:17 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001079973-25-000450 |
| 2025-03-2407:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001079973-25-000446 |
| 2025-02-2616:31 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001079973-25-000324 |
| 2024-12-1917:22 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001079973-24-001742 |
| 2024-11-1316:33 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001799191-24-000030 |
| 2024-11-1316:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001799191-24-000028 |
| 2024-11-1206:04 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001079973-24-001491 |
| 2024-09-2309:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001553350-24-000088 |
| 2024-08-2008:20 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-24-203246 |
| 2024-08-1316:17 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001799191-24-000022 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.